ILLUMINA INC (ILU.DE) Stock Fundamental Analysis

FRA:ILU • US4523271090

111.74 EUR
+7.7 (+7.4%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

Overall ILU gets a fundamental rating of 6 out of 10. We evaluated ILU against 18 industry peers in the Life Sciences Tools & Services industry. ILU scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ILU is not valued too expensively and it also shows a decent growth rate. This makes ILU very considerable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • ILU had positive earnings in the past year.
  • In the past year ILU had a positive cash flow from operations.
  • In multiple years ILU reported negative net income over the last 5 years.
  • ILU had a positive operating cash flow in each of the past 5 years.
ILU.DE Yearly Net Income VS EBIT VS OCF VS FCFILU.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B -2B -3B -4B

1.2 Ratios

  • ILU has a better Return On Assets (12.79%) than 94.44% of its industry peers.
  • Looking at the Return On Equity, with a value of 31.22%, ILU belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • ILU has a Return On Invested Capital of 13.63%. This is amongst the best in the industry. ILU outperforms 94.44% of its industry peers.
Industry RankSector Rank
ROA 12.79%
ROE 31.22%
ROIC 13.63%
ROA(3y)-6.03%
ROA(5y)-9.81%
ROE(3y)-13.51%
ROE(5y)-20.03%
ROIC(3y)N/A
ROIC(5y)N/A
ILU.DE Yearly ROA, ROE, ROICILU.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40 -60

1.3 Margins

  • ILU has a better Profit Margin (19.57%) than 88.89% of its industry peers.
  • In the last couple of years the Profit Margin of ILU has remained more or less at the same level.
  • The Operating Margin of ILU (20.29%) is better than 88.89% of its industry peers.
  • In the last couple of years the Operating Margin of ILU has grown nicely.
  • With an excellent Gross Margin value of 66.61%, ILU belongs to the best of the industry, outperforming 94.44% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ILU has remained more or less at the same level.
Industry RankSector Rank
OM 20.29%
PM (TTM) 19.57%
GM 66.61%
OM growth 3Y36.82%
OM growth 5Y2.01%
PM growth 3YN/A
PM growth 5Y-0.68%
GM growth 3Y0.64%
GM growth 5Y-0.57%
ILU.DE Yearly Profit, Operating, Gross MarginsILU.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ILU is still creating some value.
  • The number of shares outstanding for ILU has been reduced compared to 1 year ago.
  • Compared to 5 years ago, ILU has more shares outstanding
  • ILU has a better debt/assets ratio than last year.
ILU.DE Yearly Shares OutstandingILU.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ILU.DE Yearly Total Debt VS Total AssetsILU.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • ILU has an Altman-Z score of 4.19. This indicates that ILU is financially healthy and has little risk of bankruptcy at the moment.
  • ILU's Altman-Z score of 4.19 is amongst the best of the industry. ILU outperforms 88.89% of its industry peers.
  • ILU has a debt to FCF ratio of 2.14. This is a good value and a sign of high solvency as ILU would need 2.14 years to pay back of all of its debts.
  • ILU has a Debt to FCF ratio of 2.14. This is amongst the best in the industry. ILU outperforms 100.00% of its industry peers.
  • A Debt/Equity ratio of 0.55 indicates that ILU is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ILU (0.55) is comparable to the rest of the industry.
  • Although ILU does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 2.14
Altman-Z 4.19
ROIC/WACC1.29
WACC10.57%
ILU.DE Yearly LT Debt VS Equity VS FCFILU.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • ILU has a Current Ratio of 2.08. This indicates that ILU is financially healthy and has no problem in meeting its short term obligations.
  • ILU has a better Current ratio (2.08) than 83.33% of its industry peers.
  • A Quick Ratio of 1.72 indicates that ILU should not have too much problems paying its short term obligations.
  • ILU has a Quick ratio of 1.72. This is amongst the best in the industry. ILU outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.08
Quick Ratio 1.72
ILU.DE Yearly Current Assets VS Current LiabilitesILU.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • ILU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 97.96%, which is quite impressive.
  • The Earnings Per Share has been growing slightly by 1.51% on average over the past years.
  • The Revenue has decreased by -0.66% in the past year.
  • ILU shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.04% yearly.
EPS 1Y (TTM)97.96%
EPS 3Y31.77%
EPS 5Y1.51%
EPS Q2Q%56.98%
Revenue 1Y (TTM)-0.66%
Revenue growth 3Y-1.78%
Revenue growth 5Y6.04%
Sales Q2Q%4.98%

3.2 Future

  • Based on estimates for the next years, ILU will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.14% on average per year.
  • ILU is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.06% yearly.
EPS Next Y6.75%
EPS Next 2Y10.5%
EPS Next 3Y9.64%
EPS Next 5Y12.14%
Revenue Next Year5.78%
Revenue Next 2Y5.64%
Revenue Next 3Y5.85%
Revenue Next 5Y6.06%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ILU.DE Yearly Revenue VS EstimatesILU.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
ILU.DE Yearly EPS VS EstimatesILU.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 27.19, which means the current valuation is very expensive for ILU.
  • ILU's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 27.10, ILU is valued at the same level.
  • With a Price/Forward Earnings ratio of 25.50, ILU can be considered very expensive at the moment.
  • ILU's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. ILU is around the same levels.
Industry RankSector Rank
PE 27.19
Fwd PE 25.5
ILU.DE Price Earnings VS Forward Price EarningsILU.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 61.11% of the companies in the same industry are more expensive than ILU, based on the Enterprise Value to EBITDA ratio.
  • ILU's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ILU is cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.67
EV/EBITDA 16.44
ILU.DE Per share dataILU.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ILU does not grow enough to justify the current Price/Earnings ratio.
  • ILU has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.03
PEG (5Y)18.01
EPS Next 2Y10.5%
EPS Next 3Y9.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ILU does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ILLUMINA INC

FRA:ILU (2/27/2026, 7:00:00 PM)

111.74

+7.7 (+7.4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-05
Earnings (Next)05-06
Inst Owners104.7%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap17.07B
Revenue(TTM)4.34B
Net Income(TTM)850.00M
Analysts72.31
Price Target114.81 (2.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.07%
Min EPS beat(2)7.62%
Max EPS beat(2)12.52%
EPS beat(4)4
Avg EPS beat(4)9.19%
Min EPS beat(4)1.33%
Max EPS beat(4)15.27%
EPS beat(8)6
Avg EPS beat(8)14.27%
EPS beat(12)10
Avg EPS beat(12)229.92%
EPS beat(16)13
Avg EPS beat(16)175.39%
Revenue beat(2)1
Avg Revenue beat(2)1.24%
Min Revenue beat(2)-0.28%
Max Revenue beat(2)2.75%
Revenue beat(4)1
Avg Revenue beat(4)0.08%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)2.75%
Revenue beat(8)3
Avg Revenue beat(8)-0.09%
Revenue beat(12)5
Avg Revenue beat(12)-0.28%
Revenue beat(16)5
Avg Revenue beat(16)-0.88%
PT rev (1m)3.26%
PT rev (3m)10.89%
EPS NQ rev (1m)-6.53%
EPS NQ rev (3m)-5.22%
EPS NY rev (1m)0.04%
EPS NY rev (3m)2.37%
Revenue NQ rev (1m)1.3%
Revenue NQ rev (3m)1.48%
Revenue NY rev (1m)3.03%
Revenue NY rev (3m)3.79%
Valuation
Industry RankSector Rank
PE 27.19
Fwd PE 25.5
P/S 4.64
P/FCF 21.67
P/OCF 18.69
P/B 7.41
P/tB 14.41
EV/EBITDA 16.44
EPS(TTM)4.11
EY3.68%
EPS(NY)4.38
Fwd EY3.92%
FCF(TTM)5.16
FCFY4.62%
OCF(TTM)5.98
OCFY5.35%
SpS24.06
BVpS15.08
TBVpS7.76
PEG (NY)4.03
PEG (5Y)18.01
Graham Number37.35
Profitability
Industry RankSector Rank
ROA 12.79%
ROE 31.22%
ROCE 17.41%
ROIC 13.63%
ROICexc 20.13%
ROICexgc 32.79%
OM 20.29%
PM (TTM) 19.57%
GM 66.61%
FCFM 21.44%
ROA(3y)-6.03%
ROA(5y)-9.81%
ROE(3y)-13.51%
ROE(5y)-20.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y1.94%
ROICexgc growth 5Y5.2%
ROICexc growth 3Y74.03%
ROICexc growth 5Y4.4%
OM growth 3Y36.82%
OM growth 5Y2.01%
PM growth 3YN/A
PM growth 5Y-0.68%
GM growth 3Y0.64%
GM growth 5Y-0.57%
F-Score8
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 2.14
Debt/EBITDA 1.29
Cap/Depr 54.81%
Cap/Sales 3.41%
Interest Coverage 9.27
Cash Conversion 93.74%
Profit Quality 109.53%
Current Ratio 2.08
Quick Ratio 1.72
Altman-Z 4.19
F-Score8
WACC10.57%
ROIC/WACC1.29
Cap/Depr(3y)45.45%
Cap/Depr(5y)67.5%
Cap/Sales(3y)3.56%
Cap/Sales(5y)5.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.96%
EPS 3Y31.77%
EPS 5Y1.51%
EPS Q2Q%56.98%
EPS Next Y6.75%
EPS Next 2Y10.5%
EPS Next 3Y9.64%
EPS Next 5Y12.14%
Revenue 1Y (TTM)-0.66%
Revenue growth 3Y-1.78%
Revenue growth 5Y6.04%
Sales Q2Q%4.98%
Revenue Next Year5.78%
Revenue Next 2Y5.64%
Revenue Next 3Y5.85%
Revenue Next 5Y6.06%
EBIT growth 1Y36.38%
EBIT growth 3Y34.38%
EBIT growth 5Y8.17%
EBIT Next Year30.31%
EBIT Next 3Y19.36%
EBIT Next 5Y16.64%
FCF growth 1Y31.31%
FCF growth 3YN/A
FCF growth 5Y0.88%
OCF growth 1Y28.91%
OCF growth 3Y40.15%
OCF growth 5Y-0.02%

ILLUMINA INC / ILU.DE FAQ

What is the ChartMill fundamental rating of ILLUMINA INC (ILU.DE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to ILU.DE.


What is the valuation status for ILU stock?

ChartMill assigns a valuation rating of 4 / 10 to ILLUMINA INC (ILU.DE). This can be considered as Fairly Valued.


How profitable is ILLUMINA INC (ILU.DE) stock?

ILLUMINA INC (ILU.DE) has a profitability rating of 7 / 10.


Can you provide the financial health for ILU stock?

The financial health rating of ILLUMINA INC (ILU.DE) is 8 / 10.